Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
#SunPharma #Semaglutide #GenericDrugs #Pharmaceuticals #Healthcare #Type2Diabetes #DiabetesCare #SouthAfrica #SAHPRA #DrugApproval #PharmaNews #PharmaIndustry #PharmaInnovation #GenericMedicines #AffordableHealthcare #PatientAccess #HealthcareInnovation #LifeSciences #Biopharma #GlobalHealthcare Sun Pharma launches generic semaglutide in South Africa Sun Pharmas approval to launch generic semaglutide in South Africa marks another step toward improving treatment accessibility
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, initially used to treat type 2 diabetes
Lilly has given no indication it will lower list prices
Evidence-Based Supplements for the Enhancement of Athletic Performance
Some cause hunger, while others remind you that you already have too much to eat
Luo G, Liu H, Lu H (2016) Glucagon-like peptide-1(GLP-1) receptor agonists: potential to reduce fracture risk in diabetic patients
